By Josh White
Date: Thursday 04 Jan 2024
(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said in a year-end update on Thursday that its primary focus remained on realising the full potential of its XF-73 Nasal asset.
By Alexander Bueso
Date: Sunday 29 Oct 2023
(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares.
By Josh White
Date: Thursday 13 Apr 2023
(Sharecast News) - Biotechnology company Destiny Pharma reported a loss before tax of £7.7m in its 2022 results on Thursday, widening from £6.3m in the prior year.
Currency | UK Pounds |
Share Price | 25.50p |
Change Today | -2.00p |
% Change | -7.27 % |
52 Week High | 82.00 |
52 Week Low | 24.50 |
Volume | 467,239 |
Shares Issued | 95.31m |
Market Cap | £24.30m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
17:08 | 10,000 @ 25.50p |
15:47 | 4,000 @ 26.45p |
15:40 | 15,410 @ 25.38p |
15:40 | 586 @ 27.00p |
15:40 | 35 @ 27.00p |
You are here: research